JAGSNPHARM

Jagsonpal Pharmaceuticals Share Price Jagsonpal Pharmaceuticals

₹318.2
-4.95 (-1.53%)
20 April, 2024 11:57 BSE: 507789 NSE: JAGSNPHARMISIN: INE048B01027

Start SIP in Jagsonpal Pharmaceuticals

Start SIP

Jagsonpal Pharmaceuticals Performance

Day Range

  • Low 313
  • High 320
₹ 318

52 Week Range

  • Low 274
  • High 515
₹ 318
  • Open Price314
  • Previous Close323
  • Volume21550

Jagsonpal Pharmaceuticals Share Price

  • Over 1 Month +11.65%
  • Over 3 Month -17.16%
  • Over 6 Month -24.21%
  • Over 1 Year -11.66%

Jagsonpal Pharmaceuticals Key Statistics

P/E Ratio 34.3
PEG Ratio 1.1
Market Cap Cr 841
Price to Book Ratio 5.3
EPS 11
Dividend 1.6
Relative Strength Index 58.36
Money Flow Index 79.7
MACD Signal -1.27
Average True Range 14.16
Jagsonpal Pharmaceuticals Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 47586055
Operating Expenses Qtr Cr 44495250
Operating Profit Qtr Cr 3895
Depreciation Qtr Cr 0000
Interest Qtr Cr 0000
Tax Qtr Cr 1232
Net Profit Qtr Cr 4776
IndicatorMar 2023
Total Revenue Annual Cr 242
Operating Expenses Annual Cr 203
Operating Profit Annual in Cr 34
Depreciation Cr 1
Interest Annual Cr 0
Tax Annual Cr 8
Net Profit Annual Cr 27
IndicatorMar 2023
Cash from Operating Activity Annual Cr 47
Cash from Investing Activity Annual Cr -58
Cash from Financing Annual Activity Cr 0
Net Cash Flow Annual Cr -11
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 159
Fixed Assets Annual Cr 24
Total Non Current Assets Annual Cr 30
Total Current Assets Annual Cr 165
Total Assets Annual Cr 195
IndicatorMar 2023
Book Value Per Share Annual Rs 61
ROE Annual % 17
ROCE Annual % 23
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 17
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual -
EBDIT Annual Margin %

Jagsonpal Pharmaceuticals Technicals

EMA & SMA

Current Price
₹318.2
-4.95 (-1.53%)
pointer
  • Bullish Moving Average
  • ___
  • 11
  • Bearish Moving Average
  • ___
  • 5
  • 20 Day
  • ₹302.66
  • 50 Day
  • ₹312.12
  • 100 Day
  • ₹334.75
  • 200 Day
  • ₹353.22
  • 20 Day
  • ₹296.56
  • 50 Day
  • ₹301.58
  • 100 Day
  • ₹346.02
  • 200 Day
  • ₹379.92

Jagsonpal Pharmaceuticals Resistance and Support

PIVOT
₹317.12
Resistance
First Resistance 321.18
Second Resistance 324.17
Third Resistance 328.23
RSI 58.36
MFI 79.70
MACD Single Line -1.27
MACD 2.64
Support
First Resistance 314.13
Second Resistance 310.07
Third Resistance 307.08

Jagsonpal Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 23,651 1,303,643 55.12
Week 84,931 4,005,346 47.16
1 Month 42,219 2,468,110 58.46
6 Month 42,290 2,538,245 60.02

Jagsonpal Pharmaceuticals Result Highlights

Jagsonpal Pharmaceuticals Synopsis

NSE-Medical-Diversified

Jagsonpal Pharma is involved in the business activities of Manufacture of homoeopathic or biochemic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 236.71 Cr. and Equity Capital is Rs. 13.10 Cr. for the Year ended 31/03/2023. Jagsonpal Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 17/08/1978 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1978PLC009181 and registration number is 009181.
Market Cap 841
Sales 221
Shares in Float 0.85
No of funds
Yield 1.56
Book Value 5.25
U/D Vol ratio 0.8
LTDebt / Equity
Alpha -0.07
Beta 0.64

Jagsonpal Pharmaceuticals

Owner NameMar-24Dec-23Sep-23Jun-23
Promoters 68.09%68.48%68.71%68.71%
Mutual Funds
Foreign Portfolio Investors 0.73%0.53%0.38%0.37%
Financial Institutions/ Banks
Individual Investors 20.68%21.94%21.99%22.84%
Others 10.5%9.05%8.92%8.08%

Jagsonpal Pharmaceuticals Management

Name Designation
Mr. Rajpal Singh Kochhar Chairman Emeritus
Mr. Manish Gupta Managing Director
Mr. Harsha Raghavan Chairman & Non-Exe.Director
Mr. Prithipal Singh Kochhar Non Executive Director
Mr. Debasis Bikash Nandy Independent Director
Ms. Radhika Madhukar Dudhat Independent Director
Ms. Pallavi Dinodia Gupta Independent Director

Jagsonpal Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Jagsonpal Pharmaceuticals Corporate Action

Date Purpose Remarks
2024-02-02 Quarterly Results
2023-11-03 Quarterly Results
2023-08-02 Quarterly Results
2023-05-23 Audited Results & Dividend
2023-02-08 Quarterly Results
Date Purpose Remarks
2023-08-21 FINAL Rs.5.00 per share(100%)Dividend
2021-11-01 INTERIM Rs.4.00 per share(80%)Interim Dividend

Jagsonpal Pharmaceuticals MF Shareholding

Name Amount(cr)

Jagsonpal Pharmaceuticals FAQs

What is Share Price of Jagsonpal Pharmaceuticals ?

Jagsonpal Pharmaceuticals share price is ₹318 As on 20 April, 2024 | 11:43

What is the Market Cap of Jagsonpal Pharmaceuticals ?

The Market Cap of Jagsonpal Pharmaceuticals is ₹841.3 Cr As on 20 April, 2024 | 11:43

What is the P/E ratio of Jagsonpal Pharmaceuticals ?

The P/E ratio of Jagsonpal Pharmaceuticals is 34.3 As on 20 April, 2024 | 11:43

What is the PB ratio of Jagsonpal Pharmaceuticals ?

The PB ratio of Jagsonpal Pharmaceuticals is 5.3 As on 20 April, 2024 | 11:43

Q2FY23